New Zealand Rate Hike Pushes Up Floating Home Loan Rates

New Zealand Rate Hike Pushes Up Floating Home Loan Rates

July 9, 2026

WELLINGTON, July 10, 2026, 01:05 (NZST)

Westpac, ASB and BNZ raised floating mortgage rates after the Reserve Bank of New Zealand bumped its official cash rate up to 2.50%—the country’s first increase in over three years. The central bank signaled it may need to tighten further.

The OCR is the main rate the central bank uses to guide inflation, and banks tend to push those changes onto mortgage rates, business loans, and savings. So this week’s call isn’t just a technical central-bank tweak—it means a real shift in cash flow for households facing higher food, fuel, and debt costs.

The timing came ahead of a local pause. Friday is Matariki, a public holiday in New Zealand. That made the policy shift and bank repricing the big financial events of a shorter week.

The Reserve Bank’s Monetary Policy Committee voted on Wednesday to lift the OCR by 25 basis points. The committee noted cheaper oil and petrochemical prices had lessened some short-term pressure, though said the earlier energy spike would keep working through and inflation remains above target.

The central bank says annual headline inflation likely peaked at 3.9% in the June quarter, and sees it dropping to 3.3% for the September quarter. It said “some further reduction in monetary stimulus” is probably coming, but any changes to the OCR will depend on new data and how firms set their prices.

The move marked the RBNZ’s first rate hike since May 2023, ending a hold on the OCR at 2.25% that started in November 2025. Governor Anna Breman said that softer oil prices and a cash rate still in stimulatory territory could boost growth in the second half. ANZ New Zealand chief economist Sharon Zollner said the economy didn’t need that support anymore.

Westpac is lifting all its variable home and business loan rates by 0.25 percentage point. The new rates start July 13 for new borrowers and July 16 for current customers. Fixed home loan rates will stay the same. Sarah Hearn, Westpac NZ’s managing director of product, sustainability and marketing, said the bank will keep backing “both borrowers and savers” in this tightening cycle. Westpac NZ

Westpac is lifting its Bonus Saver rate by 0.25 percentage point from July 13, but its Notice Saver stays at 3.00%. The move points to a familiar cycle—floating mortgage customers see immediate changes, savers take a partial gain, and those on fixed-rate home loans won’t face bigger payments until their deals expire.

Westpac New Zealand Economics’ Kelly Eckhold said the rate hike took markets by surprise and that the RBNZ seemed to signal more tightening ahead. Westpac said it still saw another OCR hike at the September Monetary Policy Statement and kept its year-end OCR call at 2.75% to 3.00%.

Abhijit Surya, senior Asia economist at Capital Economics, said the RBNZ’s cautious tone matched his forecast that rates move up slowly to a 3.25% top next year, with hikes probably coming every other meeting.

The central bank might be tightening policy while the recovery is still narrow. The RBNZ committee wasn’t unified on inflation: two members saw upside risks, four viewed risks about balanced. Breman said weak demand could stop firms from raising prices.

The next big test is the June-quarter CPI, out July 21. The RBNZ’s next OCR call lands Sept. 2, so officials will get one set of inflation numbers and a few weeks of bank-rate data to judge if this week’s move signals a new tightening cycle or just a tentative step.

Mateusz Ługowik

Mateusz Ługowik is a senior markets reporter at Bez-kabli.pl, specializing in technology stocks, artificial intelligence and global financial markets. A graduate of the University of Gdańsk, he previously worked in investment research and market analysis. His coverage helps readers understand the key trends, companies and innovations influencing investors worldwide.

Stock Market Today

  • FTSE 100 Drops 0.61% as AstraZeneca Hit by Drug Trial Miss
    July 9, 2026, 9:41 AM EDT. The FTSE 100 fell 0.61% to 10,424.59 after AstraZeneca shares sank. Its heart drug Wainua missed the primary endpoint in a key trial, wiping as much as £23.3 billion from AstraZeneca's value. The news threw a wrench in AstraZeneca's $80 billion revenue target for 2030, according to BofA's Sachin Jain. The FTSE 250 managed a 0.28% gain, boosted by Computacenter after the company said first-half profit could double thanks to strong demand and AI contracts. Playtech was also among the top mid-cap movers. Trading stayed volatile with Middle East worries and moving oil prices. In the U.S., Ionis fell in premarket, while rivals Alnylam and BridgeBio jumped 11-16% on their approved treatments for the same heart condition.